Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age
Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age
To estimate the percentage of children with serum IGF-1 > 2 standard deviation (compared to a
 child of the same gender and age and without growth hormone (GH) deficiency) 9 months and 12
 months after initiation of GH treatment.
Inclusion Criteria:

 -  Chronological age between 4 and 9 years for a boy and 4 and 7 years for a girl.

 -  Measured Height < -2.5 Standard Deviation

 Exclusion Criteria:

 -  Pubertal signs ie: testis volume > or = 4 ml in boys and breast stage > or = B2
 (Tanner)

 -  Serious chronic disease (diabetes, renal insufficiency, heart failure, hepatic
 insufficiency, neoplasia)